UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 抗Ro/SSA抗体および抗La/SSB抗体の抗原抗体系the anti ro ssa and anti la ssb antigen antibody systems [show details]
… Additionally, anti-Ro/SSA antibodies (with or without anti-La/SSB antibodies) identify pregnant women who are at increased risk of having a child with neonatal lupus syndrome . Anti-Ro/SSA antibodies may also …
2. 抗糸球体基底膜疾患（グッドパスチャー病）：発症機序、臨床症状、診断anti gbm goodpasture disease pathogenesis clinical manifestations and diagnosis [show details]
… cytoplasmic antibodies (ANCA) should be performed in all patients who are diagnosed with anti-GBM disease. The presence of both anti-GBM antibodies and ANCA supports a diagnosis of double-positive anti-GBM and …
3. 抗GBM抗体（グッドパスチャー）病の治療treatment of anti gbm antibody goodpastures disease [show details]
…positive anti-GBM antibody, should prompt a further course of plasmapheresis. If antibody levels remain elevated, the immunosuppressive regimen above should be continued. If the anti-GBM antibody titers …
4. 抗IgE療法anti ige therapy [show details]
…neutralization therapy with anti-IgE monoclonal antibody, with a focus on the treatment of asthma. Other promising approaches to reducing IgE, as well as investigational applications of anti-IgE to other disorders …
5. 肺移植における抗体媒介性拒絶反応の評価および治療evaluation and treatment of antibody mediated lung transplant rejection [show details]
…immunoglobulin . Serum panel reactive antibodies (anti-HLA antibodies) were absent, possibly due to the relatively insensitive assay used at the time, but anti-endothelial antibodies were noted. C4d deposition …

Related Links

KAKEN — Research Projects | 原発性胆汁性肝硬変における ...

原発性胆汁性肝硬変(PBC)に特徴的な抗ミトコンコンドリア抗体の対応抗原であるpyruvate dehydrogenase(PDH)の細胞性免疫について検討した。PDH-E2 componentのcDNAをヒト肝臓より作成し、pREP4にクローニングした。EB virus transformed B cellは患者PBMCをcyclosporin存在下にEB virus産生B95-8とともに培養し3週間培養して ...

KAKEN — 研究課題をさがす | 原発性胆汁性肝硬変における ...

原発性胆汁性肝硬変(PBC)に特徴的な抗ミトコンコンドリア抗体の対応抗原であるpyruvate dehydrogenase(PDH)の細胞性免疫について検討した。PDH-E2 componentのcDNAをヒト肝臓より作成し、pREP4にクローニングした。EB virus transformed B cellは患者PBMCをcyclosporin存在下にEB virus産生B95-8とともに培養し3週間培養して ...

KAKEN — 研究課題をさがす | 1997 年度実績報告書 ...

pREP4-PDHE2はelectroporationによりEB virus transformed B cellに導入しhygromycinにてselectionを行った。mRNA、タンパク発現はdotblot、immunoprecipitationにてそれぞれ確認した。抗PDH抗体産生B細胞をクローニングすること